Welcome to PSI, the largest research institute for natural and engineering sciences in Switzerland.
Recent highlights from our research
Show filters
New insights into a rare disease
Researchers at PSI have uncovered how genetic defects damage human cilia in different ways – a step towards improving the diagnosis of primary ciliary dyskinesia, a disease that has until now been poorly understood.
Using terbium against lymphoma
Promising laboratory experiments at PSI show that radionuclide therapy with the radioactive element terbium could combat lymphoma effectively.
Using AI to identify genetic perturbations from cell images
New AI identifies genetic perturbations in chromatin – a potential approach in diagnostics and drug development.
Topic cloud
Current upgrade projects and research initiatives
Together with industry to innovation
Advancing nuclear technologies
NUKEM and Paul Scherrer Institute Sign Memorandum of Understanding to Advance Nuclear Research and Collaboration.
Zinc detected in clogged syringes
With the help of researchers at PSI, ANAXAM has been investigating, on behalf of the pharmaceutical company MSD, whether zinc may contribute to clogging of pre-filled syringes.
ESA Centre of Excellence opens in Switzerland
The opening ceremony of the “European Space Deep-Tech Innovation Centre” ESDI brought together distinguished guests.
The people at PSI
PSI’s cement whisperer
John Provis has dedicated his research career to a building material that is far more exciting than you might think.
Creating circuit diagrams of the brain
Adrian Wanner aims to map the brain’s architecture. Doing this will allow us to better understand neurodegenerative diseases like Alzheimer’s.
With pad, pencil, and algorithms
Physicist Dominik Sidler is developing fundamental theories for previously inexplicable phenomena.